BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9382535)

  • 1. [Visualising lymph nodes by aclarubicin bound to activated carbon particles in breast cancer surgery].
    Imanishi T; Hagiwara A; Sawai K; Yamaguchi T; Sakakura C; Shirasu M; Ohgaki M; Yamasaki J; Togawa T; Takahashi T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1796-8. PubMed ID: 9382535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trial of a treatment for lymph node metastases in patients with breast cancer using aclarubicin bound to activated carbon particles].
    Imanishi T; Sakakibara T; Yamazaki J; Ohyama T; Shirasu M; Tsujimoto H; Ohgaki M; Shimotsuma M; Hagiwara A; Sawai K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1635-7. PubMed ID: 7574780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extended radical mastectomy using preoperative local injection of activated carbon particle adsorbing aclarubicin (ACR-CH)].
    Asaga T; Kobayashi O; Masuzawa C; Motohashi H; Okamoto T
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):313-9. PubMed ID: 2359386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer--a pilot study.
    Hagiwara A; Takahashi T; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Imanishi T; Yamasaki J; Takemoto Y; Kageyama N
    Anticancer Drugs; 1997 Aug; 8(7):666-70. PubMed ID: 9311442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale of lymph node dissection for breast cancer--from the viewpoint of analysis of axillary lymphatic flow using activated carbon particle CH40.
    Sawai K; Hagiwara A; Shimotsuma M; Sakakibara T; Imanishi T; Takemoto Y; Takahashi T
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():30-5. PubMed ID: 8702308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adsorption and desorption of aclarubicin into and from activated carbon particles as drug carrier--an in vitro study].
    Matsumoto S; Iwamoto A; Yoneyama C; Hagiwara A; Takahashi T; Yoshikawa H; Muranishi S
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):227-31. PubMed ID: 1992916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Wu WJ; Zeng J; Pan CE
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of parasternal (Ps) and supraclavicular (Sc) node dissection combined with targeting chemotherapy (activated carbon particle adsorbing aclarubicin) in breast cancer with Ps node involvement--usefulness of extended surgery for improvement of prognosis].
    Asaga T; Masuzuma C; Yoshida A
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):528-32. PubMed ID: 7969020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study.
    Hagiwara A; Takahashi T; Sawai K; Sakakura C; Hoshima M; Ohyama T; Ohgaki M; Imanishi T; Yamamoto A; Muranishi S
    Cancer; 1996 Nov; 78(10):2199-209. PubMed ID: 8918415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer].
    Wu WJ; Pan CE; Zeng J
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1001-4. PubMed ID: 16109560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of cytotoxicity in mouse regional lymph nodes by local tissue injection of aclacinomycin A.
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Yamane T; Itoh M; Sasabe T; Lee M; Shobayashi S
    Lymphology; 1992 Sep; 25(3):114-9. PubMed ID: 1434786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective distribution of aclarubicin to regional lymph nodes with a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Matsumoto S; Muranishi S
    Anticancer Drugs; 1991 Jun; 2(3):261-6. PubMed ID: 1802020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
    Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
    Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
    Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
    Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of therapeutic efficacy of aclarubicin against lymph node metastases using a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Sakakura C; Takahashi T; Sawai K; Hagiwara A; Ito M; Shobayashi S; Sasaki S; Ozaki K; Shirasu M
    Anticancer Drugs; 1992 Jun; 3(3):233-6. PubMed ID: 1525403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymphadenectomy for breast cancer in a community managed care setting.
    Guenther JM; Krishnamoorthy M; Tan LR
    Cancer J Sci Am; 1997; 3(6):336-40. PubMed ID: 9403045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of sentinel and axillary node involvement in breast cancer].
    Papa MZ; Bersuk D; Koler M; Klein E; Sareli M; Ben-Ari G
    Harefuah; 1997 Nov; 133(10):428-30, 504, 503. PubMed ID: 9418311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.